pharmaphorum August 28, 2024
Phil Taylor

A virtual voice assistant that calls patients after heart procedures can allow them to be discharged from hospital earlier and identify patients who may need follow-up interventions, according to a new study.

The TeleTAVI trial was carried out in 274 people with a narrowing (stenosis) of the aortic valve who needed a replacement implanted and used a voice assistant called Lola, created by the Spanish company Tucuvi. It will be presented at the European Society of Cardiology (ESC) annual congress that gets underway in London on Friday.

In the study, patients undergoing a transcatheter aortic valve implantation (TAVI) procedure were given the option of receiving follow-up telephone calls with the voice assistant, which uses artificial intelligence and natural language processing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Technology, Voice Assistant
Related Articles:
Meta’s new BLT architecture replaces tokens to make LLMs more efficient and versatile
Johns Hopkins Medicine inks AI deal with Abridge
Congress' AI report leaves some tech-watchers on edge
Only 20% of AI devices for children used pediatric data to train: 3 notes
Top Decentralized AI Projects Of 2025 Amid OpenAI Copyright Concerns

Share This Article